The structure of Escherichia coli cytosine deaminase

被引:123
作者
Ireton, GC
McDermott, G
Black, ME
Stoddard, BL
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Grad Program Mol & Cell Biol, Seattle, WA 98109 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Nal Lab Adv Light Source, Berkeley, CA 94720 USA
[4] Washington State Univ, Coll Pharm, Dept Pharmaceut, Pullman, WA 99164 USA
关键词
cytosine deaminase; prodrug gene therapy; protein structure; X-ray crystallography; enzyme mechanism;
D O I
10.1006/jmbi.2001.5277
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosine deaminase (CD) catalyzes the deamination of cytosine, producing uracil. This enzyme is present in prokaryotes and fungi (but not multicellular eukaryotes) and is an important member of the pyrimidine salvage pathway in those organisms. The same enzyme also catalyzes the conversion of 5-fluorocytosine to 5-fluorouracil; this activity allows the formation of a cytotoxic chemotherapeutic agent from a non-cytotoxic precursor. The enzyme is of widespread interest both for antimicrobial drug design and for gene therapy applications against tumors. The structure of Esclierichia coli CD has been determined in the presence and absence of a bound mechanism-based inhibitor. The enzyme forms an (up), barrel structure with structural similarity to adenosine deaminase, a relationship that is undetectable at the sequence level, and no similarity to bacterial cytidine deaminase. The enzyme is packed into a hexameric assembly stabilized by a unique domain-swapping interaction between enzyme subunits. The active site is located in the mouth of the enzyme barrel and contains a bound iron ion that coordinates a hydroxyl nucleophile. Substrate binding involves a significant conformational change that sequesters the reaction complex from solvent. (C) 2002 Academic Press.
引用
收藏
页码:687 / 697
页数:11
相关论文
共 43 条
[1]  
AUSTIN EA, 1993, MOL PHARMACOL, V43, P380
[2]   A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii:: why urea hydrolysis casts two nickels [J].
Benini, S ;
Rypniewski, WR ;
Wilson, KS ;
Miletti, S ;
Ciurli, S ;
Mangani, S .
STRUCTURE, 1999, 7 (02) :205-216
[3]   CYTIDINE DEAMINASE - THE 2-CENTER-DOT-3-ANGSTROM CRYSTAL-STRUCTURE OF AN ENZYME - TRANSITION-STATE ANALOG COMPLEX [J].
BETTS, L ;
XIANG, SB ;
SHORT, SA ;
WOLFENDEN, R ;
CARTER, CW .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (02) :635-656
[4]   ASSESSMENT OF PHASE ACCURACY BY CROSS VALIDATION - THE FREE R-VALUE - METHODS AND APPLICATIONS [J].
BRUNGER, AT .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1993, 49 :24-36
[5]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[6]   Ribbons [J].
Carson, M .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :493-505
[7]  
DIPIRO JT, 1997, PHARM PATHOPHYSIOLOG
[8]   Preparation of selenomethionyl proteins for phase determination [J].
Doublie, S .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :523-530
[9]   BINDING OF PYRIMIDIN-2-ONE RIBONUCLEOSIDE BY CYTIDINE DEAMINASE AS THE TRANSITION-STATE ANALOG 3,4-DIHYDROURIDINE AND THE CONTRIBUTION OF THE 4-HYDROXYL GROUP TO ITS BINDING-AFFINITY [J].
FRICK, L ;
YANG, C ;
MARQUEZ, VE ;
WOLFENDEN, R .
BIOCHEMISTRY, 1989, 28 (24) :9423-9430
[10]  
Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO